The present invention relates to a solid oral pharmaceutical composition comprising Lurasidone or its pharmaceutically acceptable salts, esters, solvates, polymorphs, stereoisomers or mixtures thereof, wherein the composition is substantially free of binder. The invention further relates to processes for the preparation of such compositions comprising Lurasidone.